Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alberto Giovanni Leone"'
Autor:
Matteo Lambertini, Filippo Pietrantonio, Dario Trapani, Francesco Perrone, Rossana Berardi, Saverio Cinieri, Chiara Cassani, Amelia Barcellini, Filippo Ghelardi, Alberto Giovanni Leone, Stefania Bonadonna, Marianna Sirico, Barbara Tagliaferri, Stefano Maccarone, Davide Dalu, Lorenzo Ruggieri, Simone Nardin, Nicla La Verde
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Transgender and gender-diverse (TGD) individuals face an elevated risk of cancer in comparison with the general population. This increased risk is primarily attributed to an imbalanced exposure to modifiable risk factors and a limited adherence to ca
Externí odkaz:
https://doaj.org/article/cd6d545d3744429793ab86b364cf13fe
Autor:
Alberto Giovanni Leone, Raffaella Casolino, Dario Trapani, Rosalba Miceli, Massimo Massagrande, Federica Morano, Nicla La Verde, Davide Dalu, Rossana Berardi, Silvia Marsoni, Matteo Lambertini, Bianca Iula, Eva Carieri, Manlio Converti, Massimo Di Maio, Giordano Domenico Beretta, Francesco Perrone, Filippo Pietrantonio, Saverio Cinieri
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102277- (2023)
Summary: Transgender and gender-diverse individuals experience substantial health disparities across the cancer care continuum. Despite well recognized unique healthcare needs, there are barriers in accessing cancer prevention and treatment services,
Externí odkaz:
https://doaj.org/article/b5199cbee2264e5cb366a24df25b899c
Autor:
Achille Bottiglieri, Pierangela Sepe, Marco Stellato, Chiara Pircher, Giuseppe Fotia, Alberto Giovanni Leone, Valentina Guadalupi, Melanie Claps, Patrizia Giannatempo, Elena Verzoni, Giuseppe Procopio
Publikováno v:
Cancer Management and Research. 14:3071-3081
Renal cell carcinoma (RCC) is the fourteenth most common cancer worldwide. In about 55% of cases, it is diagnosed at a localised and/or locally advanced stage and therefore amenable to a curative approach. Although nephrectomy still represents the co
Autor:
Caterina Zanella, Alberto Giovanni Leone, Luca Zambelli, Achille Bottiglieri, Luca Canziani, Marta Brambilla, Giuseppe Lo Russo, Marco Platania, Filippo De Braud, Mario Occhipinti
Publikováno v:
Tumori Journal. 108:NP11-NP14
Paraneoplastic syndromes occur in about 0.1% of patients affected by neoplastic diseases. In some types of tumors, such as Small Cell Lung Cancer (SCLC), Thymoma, and particular forms of Plasmacytoma, the association with Paraneoplastic Neurological
Autor:
Dominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, Joseph J. Zhao, Jeremy Chee Seong Tey, Raghav Sundar, Filippo Pietrantonio
Publikováno v:
JAMA oncology.
ImportanceImmune checkpoint inhibitors (ICIs) have improved survival outcomes of patients with advanced esophageal squamous cell carcinoma in both first- and second-line settings. However, the benefit of ICIs in patients with low programmed death lig
Autor:
Alberto Giovanni Leone, Dario Trapani, Matthew B. Schabath, Joshua D. Safer, N. F. N. Scout, Matteo Lambertini, Rossana Berardi, Silvia Marsoni, Francesco Perrone, Saverio Cinieri, Rosalba Miceli, Federica Morano, Filippo Pietrantonio
Publikováno v:
JAMA Oncology. 9:556
ImportanceTransgender and gender-diverse individuals face unique challenges, including barriers to health care access and inequities in treatment, that may influence cancer risk and outcomes.ObservationsIn this narrative review, a scoping review was
Autor:
Filippo Pietrantonio, Alessandra Raimondi, Sara Lonardi, Sabina Murgioni, Giovanni Gerardo Cardellino, Stefano Tamberi, Antonia Strippoli, Federica Palermo, Michele Prisciandaro, Giovanni Randon, Francesca Corti, Francesca Bergamo, Floriana Nappo, Alberto Giovanni Leone, Giuseppe Leoncini, Giovanna Sabella, Kristiyana Kaneva, Carlo Sposito, Maria Di Bartolomeo, Vincenzo Mazzaferro
Publikováno v:
Journal of Clinical Oncology. 41:358-358
358 Background: In resectable GAC/GEJAC, MSI status is associated with better survival and potential lack of benefit from chemotherapy. Given the high responsiveness of MSI tumors to immunotherapy, neoadjuvant or definitive dual CTLA-4/PD(L)-1 inhibi
Autor:
Beatrice Borelli, Stefania Crucitta, Alessandra Boccaccino, Maria Antista, Carlotta Antoniotti, Federica Marmorino, Daniele Rossini, Veronica Conca, Marco Maria Germani, Leonardo Provenzano, Andrea Spagnoletti, Alberto Giovanni Leone, Federico Cucchiara, Filippo Pietrantonio, Marzia Del Re, Romano Danesi, Gianluca Masi, Chiara Cremolini, Roberto Moretto
Publikováno v:
Tumori Journal. :030089162211479
Background: Trifluridine/tipiracil and regorafenib are indicated for metastatic colorectal cancer (mCRC) patients’ refractory to standard chemotherapy. No prognostic or predictive biomarkers are available for these agents. Methods: We assessed mess
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease
Autor:
Andrea Spagnoletti, Marco Platania, Marta Brambilla, Mario Occhipinti, Luca Canziani, Antonello Cabras, Leonardo Provenzano, Alberto Giovanni Leone, Paolo Ambrosini, Arsela Prelaj
The use of immune checkpoint inhibitors (ICIs) offers new possibilities in modern treatment of many types of cancers. Few data regarding safety and efficacy of ICIs are available, and are mainly from retrospective studies and case reports rather than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcad4b2e024facbe8c2aa02d37245ed
http://hdl.handle.net/11573/1602956
http://hdl.handle.net/11573/1602956
Autor:
Paolo Manca, Alberto Giovanni Leone, Carlotta Antoniotti, Alessandra Raimondi, Roberto Murialdo, Elisa Sottotetti, Valeria Smiroldo, Salvatore Corallo, Francesca Corti, Antonia Martinetti, Giovanni Fucà, Federica Morano, Patrizia Racca, Margherita Ratti, Letizia Procaccio, Adele Busico, Giovanni Randon, Filippo Pagani, Margherita Ambrosini, Michele Prisciandaro, Sara Lonardi, Filippo Pietrantonio
Publikováno v:
Br J Cancer
INTRODUCTION: In patients with metastatic colorectal cancer (mCRC), baseline circulating tumour DNA (ctDNA) variant allele fraction (VAF) might serve as a surrogate of disease burden and should be evaluated in comparison with CEA and RECIST-defined s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7faab7c5ca2fffbbb300c72675171e26
https://europepmc.org/articles/PMC8810873/
https://europepmc.org/articles/PMC8810873/